Junction Bioscience is a pharmaceutical firm that is developing an autonomous AI scientist to guide the discovery of breakthrough drugs.
Junction Bioscience has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2024.
Junction Bioscience's investors include Y Combinator.
Junction Bioscience is headquartered in San Francisco, United States.
Junction Bioscience is a pharmaceutical firm that is developing an autonomous AI scientist to guide the discovery of breakthrough drugs.
Junction Bioscience is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Junction Bioscience — Funding & Investors." VCBacked, March 19, 2024, https://www.vcbacked.co/company/junction-bioscience. Accessed August 1, 2026.
VCBacked. (2024). Junction Bioscience — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/junction-bioscience
{{cite web |title=Junction Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/junction-bioscience |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated